Berberine is an unlicensed supplement with modest effects and limited evidence, whilst GLP-1 receptor agonists are rigorously tested, MHRA-licensed medicines with proven efficacy for type 2 diabetes management under medical supervision
Back Kolata, G, Robbins, R (17 April 2025) 'Daily pill may work as well as Ozempic for weight loss and blood sugar', The New York Times
When asked if it had any human clinical data to support its claims about weight management and GLP-1 production, a spokesman sent AgFunderNews links to three studies, although none of them demonstrated any weight loss effects
With the caveat that not all people with diabetes, cardiovascular disease, NAFLD or cancer are obese, reductions in the prevalence of obesity would be expected to also reduce the prevalence of these diseases as well
The iD system uses radiofrequency energy to selectively target and reduce stubborn fat cells